Workforce Planning for 2026

Workforce Planning for 2026: How Biotech and Pharma Can Build an AI-Ready R&D Organisation

Executive Summary

Workforce planning in 2026 looks fundamentally different from even three years ago. The rapid maturation of AI/ML in drug discovery, the rise of multimodal foundation models, and a tightening global talent market are reshaping how R&D organisations think about skills, structure, and long-term capability building.

The companies that win will be those that recognise workforce planning as a strategic, data-driven discipline—not a yearly HR exercise. This article outlines the emerging workforce dynamics shaping biotech and pharma, the skills that matter most, and a practical timeline for organisations preparing for 2026 and beyond.

Why Workforce Planning Is Entering a New Era

By 2026, biotech and pharma companies are navigating three converging forces:

1. AI/ML becoming a default layer in R&D workflows

Not as a novelty, but as a standard toolset across target identification, computational chemistry, and preclinical analytics. Organisations now require teams who can understand, validate, and operationalise these technologies—not simply procure them.

2. A persistent shortage of hybrid-skilled talent

Profiles combining biology + computation + product thinking are in high demand but remain scarce. Many companies are rethinking whether to buy, build, partner, or upskill talent.

3. Increased pressure for operational efficiency

Funding environments remain tight, and organisations are expected to do more with fewer resources. That places workforce strategy at the centre of pipeline velocity and R&D decision-making.

In this environment, workforce planning becomes a competitive differentiator, directly shaping data quality, model performance, and R&D throughput.

What “Good” Workforce Planning Looks Like in 2026

In high-performing biotech organisations, workforce planning is no longer siloed in HR. Instead, it’s:

1. Cross-functional and deeply data-driven

Workforce planning starts with a clear map of R&D workflows, bottlenecks, and required competencies. Teams benchmark skills against current and future workflows, not job titles.

1. Closely tied to AI/ML adoption roadmaps

You cannot deploy multimodal models or automated simulation pipelines without the right talent in place. Planning begins with the science and the workflows—then aligns roles accordingly.

1. Focused on hybrid skill stacks, not siloed roles

By 2026, leading organisations prioritise hybrid profiles such as:

• Computational biologists with model-interpretability fluency
• Data engineers who understand biological schemas
• AI product managers aligned to R&D realities
• Lab scientists comfortable with digital tools and automated workflows

This aligns strongly with KEMIO’s brand voice: AI is powerful only when paired with domain expertise.

1. Designed for flexibility and scenario planning

Companies model multiple headcount scenarios based on:

• Pipeline expansion or contraction
• Shifts in computational maturity
• Partnership/outsourcing strategies
• Adoption of new discovery platforms (e.g., robotic labs, generative design)

Workforce planning becomes a living system.

The Essential Skills Map for 2026

Core Scientific & Technical Skills

• Computational biology
• Multimodal data integration
• ML model evaluation and interpretability
• Structural biology + computational chemistry
• Data engineering and workflow automation

Operational Skills

• Digital lab operations
• Data governance and FAIR data management
• Workflow architecture
• Vendor/platform evaluation

Strategic Skills

• AI product management
• Translational thinking between algorithm and experimental design
• Change management

Insight: In 2026, organisations don’t need more “AI experts”—they need people who understand how AI fits into R&D workflows. This reflects the KEMIO narrative: the next frontier isn’t bigger models—it’s better workflows.

The 2026 Workforce Planning Playbook

Below is a best-practice approach KEMIO recommends to biotech and pharma clients.

Step 1: Map Current and Future Discovery Workflows (Q1 2025 – Q2 2025)

• Identify roles linked to high-friction bottlenecks
• Assess gaps in data readiness, automation, and model literacy
• Document manual steps that could be automated or augmented by ML

Output: Skills-based workflow map.

Step 2: Build a Skills Inventory and Competency Matrix (Q2 2025 – Q3 2025)

• Evaluate team capabilities against future workflows
• Categorise skills into: foundational, evolving, critical, and sunset
• Identify dependency risks (e.g., single-person expertise)

Output: Organisation-wide skills heatmap.

Step 3: Define the 2026 Organisational Model (Q3 2025 – Q4 2025)

• Determine which functions need deep computational talent
• Decide what to build internally vs. outsource
• Design hybrid teams (wet-lab + computational + data)
• Outline the AI/ML oversight and governance structure

Output: 2026 organisational blueprint.

Step 4: Launch Targeted Talent Pipelines (Q4 2025 – Q1 2026)

• Graduate talent partnerships
• Computational fellowship or rotational programmes
• Cross-training and upskilling initiatives
• Early hires in critical-path roles

Output: Hiring and upskilling plan tied to R&D priorities.

Step 5: Implement 2026 Readiness Milestones (Q1 2026 – Q4 2026)

• Deploy training on data literacy, ML basics, and automation workflows
• Evaluate model governance and workflow robustness
• Update competency matrix quarterly
• Adjust hiring strategy based on pipeline evolution

Output: Continuous workforce refresh aligned with discovery velocity.

Workforce Planning as a Strategic Advantage

By 2026, biotech and pharma organisations with the clearest talent and capability roadmap will move faster, validate more efficiently, and unlock greater value from AI-enabled discovery.

The companies that win will be those who realise:
You don’t build an AI-ready organisation by hiring more data scientists—you build it by redesigning workflows and cultivating the hybrid talent that drives them.

This is where KEMIO excels: guiding teams through the intersection of computational innovation, organisational design, and real-world R&D impact.